Description
The skeptic raised concerns that IL-1α blockade may trigger compensatory upregulation of IL-1β, IL-18, or TLR signaling pathways. This potential for pathway redundancy could undermine single-target therapeutic approaches but has not been systematically investigated.
Source: Debate session sess_sda-2026-04-01-gap-009 (Analysis: sda-2026-04-01-gap-009)